Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹44.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 33.47 per cent from ₹66.96 crore. This corresponds to a year-on-year *(YoY) decline of 33.73 per cent.
PBDT
PBDT stands at ₹194.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.22 per cent from ₹196.47 crore. This corresponds to a year-on-year *(YoY) growth of 32.78 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.08 per cent from ₹194.97 crore. This represents a 172.65 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | -0.01% | -1.55% | -8.20% | 3.23% | 13.57% | 70.27% |
| Biocon | 1.36% | 1.04% | -5.17% | -1.80% | -6.82% | 3.65% |
| Abbott India | 0.12% | -0.85% | -3.21% | -6.89% | -21.58% | 5.74% |
| Glenmark Pharma. | -0.54% | 1.43% | -1.51% | 6.13% | -7.25% | 37.92% |
| Glaxosmi. Pharma | 3.83% | 5.46% | 2.03% | -6.93% | -23.69% | 23.04% |
| Ipca Labs. | -1.18% | -1.27% | 4.10% | 12.09% | -5.55% | -0.76% |
| Ajanta Pharma | -0.26% | 0.24% | -0.69% | 9.61% | -3.37% | 1.13% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru